Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.

Prospective studies on the relationship between course of cannabis use and clinical outcome in patients with non-affective psychotic disorders are inc...
227KB Sizes 1 Downloads 6 Views

Recommend Documents

Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study.
Cannabis use has been reported to affect the course of various psychiatric disorders, however its effect on the course of major depressive disorder (MDD) is not yet clear. We used data from Wave 1 and Wave 2 of the National Epidemiologic survey on Al

Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis.
Among people at genetic risk of schizophrenia, those who use cannabis show smaller thalamic and hippocampal volumes. We evaluated this relationship in people at clinical high risk (CHR) of psychosis. The Alcohol and Drug Use Scale was used to identif

Cannabis use and treatment resistance in first episode psychosis: a natural language processing study.
Cannabis is frequently used among individuals with first episode psychosis and is associated with poor clinical outcomes. However, little is known about the effect of cannabis use on the response to antipsychotic medications and how use could affect

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
Numerous studies show the existence of a high prevalence of cannabis use among patients with psychosis. However, the differences between men and women who debut with a first episode of psychosis (FEP) regarding cannabis use have not been largely expl

Sensorimotor gating, cannabis use and the risk of psychosis.
Sensorimotor gating, measured as the modification of eye blink startle reflexes to loud acoustic stimuli by quieter preceding stimuli, is altered in those with psychosis, their relatives and those at high clinical risk for psychosis. Alterations have

Adolescent Initiation of Cannabis Use and Early-Onset Psychosis.
It is important to evaluate the impact of cannabis use on onset and course of psychotic illness, as the increasing number of novice cannabis users may translate into a greater public health burden. This study aims to examine the relationship between

The impact of cannabis use on clinical outcomes in recent onset psychosis.
There are inconsistencies in findings as to whether cannabis use has a negative impact on clinical outcomes for people with established psychosis. Effects may be more evident on patients with recent onset psychosis.

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.
Cannabis use is associated with an earlier age of onset of psychosis (AOP). However, the reasons for this remain debated.

Cannabis and psychosis: Neurobiology.
Cannabis is a known risk factor for schizophrenia, although the exact neurobiological process through which the effects on psychosis occur is not well-understood. In this review, we attempt to develop and discuss a possible pathway for the developmen

Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.
The high rate of cannabis use among patients with first-episode psychosis (FEP), as well as the associated negative impact on illness course and treatment outcomes, underlines the need for effective interventions in these populations. However, to dat